PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES COMPRISING THE B-OLIGOMER OF PERTUSSIS TOXIN OR ITS SUBUNITS

摘要

The invention provides the use of a protein selected from the B-oligomer of pertussis toxin, an individual subunit S2, S3, S4 or S5 thereof, or a combination of said subunits, for the preparation of pharmaceutical compositions comprising them for the treatment of autoimmune diseases.